mTOR – Function, Signaling Pathway and Medical Relevance
mTOR is a central enzyme (kinase) in human cells that regulates cell growth, metabolism, and cell division. It plays a key role in cancer, metabolic diseases, and the aging process.
Things worth knowing about "mTOR (mechanistic Target of Rapamycin)"
mTOR is a central enzyme (kinase) in human cells that regulates cell growth, metabolism, and cell division. It plays a key role in cancer, metabolic diseases, and the aging process.
What is mTOR?
mTOR (mechanistic Target of Rapamycin, formerly also called mammalian Target of Rapamycin) is a serine/threonine protein kinase found in nearly all eukaryotic cells. As a master regulator of cellular metabolism, mTOR coordinates the cell's response to nutrients, growth factors, energy availability, and stress signals. The enzyme belongs to the family of PI3-kinase-related kinases (PIKK) and forms two functionally distinct protein complexes: mTORC1 and mTORC2.
Mechanism of Action
mTOR integrates a wide range of intracellular and extracellular signals to control fundamental cellular processes:
- mTORC1: Promotes protein synthesis (via S6K1 and 4E-BP1), lipid synthesis, and mitochondrial biogenesis, while simultaneously inhibiting autophagy (the cellular self-cleaning process). mTORC1 responds directly to amino acids, ATP levels, and growth factors such as insulin.
- mTORC2: Regulates the cytoskeleton and cell survival signaling, and activates protein kinase B (AKT), which in turn stimulates mTORC1. mTORC2 is less sensitive to the inhibitor rapamycin.
A central signaling pathway that activates mTOR is the PI3K/AKT/mTOR pathway. This is triggered by growth factors such as insulin or IGF-1 (Insulin-like Growth Factor 1) and plays a fundamental role in regulating cell growth and survival.
Medical Significance
Cancer
In numerous cancer types, the mTOR signaling pathway is overactivated, leading to uncontrolled cell growth and tumor progression. This includes renal cell carcinoma, breast cancer, endometrial cancer, and various leukemias. Overactivation frequently arises from mutations in upstream regulators such as PTEN, PI3K, or RAS.
Metabolic Diseases
In type 2 diabetes and obesity, the mTOR pathway is chronically activated, contributing to insulin resistance. Sustained mTORC1 activation inhibits the insulin signaling pathway through a negative feedback mechanism, impairing glucose uptake in cells.
Aging and Longevity
Studies in model organisms (yeast, nematodes, fruit flies, mice) demonstrate that inhibition of mTOR extends lifespan. This effect is attributed to enhanced autophagy and improved stress resistance. Caloric restriction, one of the most robust life-extending interventions, acts in part through inhibition of mTORC1.
Neurological Disorders
Dysregulation of mTOR is associated with neurological conditions including tuberous sclerosis complex, certain forms of epilepsy, Alzheimer's disease, and autism spectrum disorders. In tuberous sclerosis, mutations in the mTOR inhibitors TSC1 and TSC2 lead to strong mTOR overactivation.
Transplantation Medicine and Immunology
mTOR plays an important role in the activation and differentiation of T lymphocytes. Inhibition of mTOR by rapamycin (sirolimus) is therefore used in transplantation medicine to prevent organ rejection.
mTOR Inhibitors
Given the central role of mTOR in disease processes, specific inhibitors have been developed:
- Rapamycin (Sirolimus): The original mTOR inhibitor, which selectively blocks mTORC1. Used as an immunosuppressant after organ transplantation.
- Everolimus and Temsirolimus: Rapamycin analogues (rapalogs) approved for various cancers, including renal cell carcinoma and pancreatic neuroendocrine tumors.
- Dual mTOR inhibitors: Newer agents that block both mTORC1 and mTORC2, currently in clinical development.
Diagnostic Relevance
Analysis of the mTOR signaling pathway is of growing importance in oncology. Molecular biomarkers such as PTEN loss, PIK3CA mutations, or elevated phospho-S6K1 levels can help identify patients most likely to benefit from mTOR-targeted therapy. These assessments are typically performed through tumor tissue analysis using immunohistochemistry or genomic sequencing.
References
- Saxton, R.A. & Sabatini, D.M. (2017). mTOR Signaling in Growth, Metabolism, and Disease. Cell, 168(6), 960-976. DOI: 10.1016/j.cell.2017.02.004
- Laplante, M. & Sabatini, D.M. (2012). mTOR Signaling in Growth Control and Disease. Cell, 149(2), 274-293. DOI: 10.1016/j.cell.2012.03.017
- National Cancer Institute (NCI) – PI3K/AKT/mTOR Pathway in Cancer: Targeted Therapy Overview. Available at: https://www.cancer.gov
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMacronutrients
Portion control
Food craving
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: mTOR (mechanistic Target of Rapamycin)-en